Phase I trial and pharmacokinetic study of tanibirumab, a fully human monoclonal antibody to vascular endothelial growth factor receptor 2, in patients with refractory solid tumors

Su Jin Lee, Seon Young Lee, Weon Sup Lee, Jin San Yoo, Jong Mu Sun, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Myung Ju Ahn, Ho Yeong Lim, Won Ki Kang, Young Suk Park

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial and pharmacokinetic study of tanibirumab, a fully human monoclonal antibody to vascular endothelial growth factor receptor 2, in patients with refractory solid tumors'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science